Intero Biosystems
- Headquarters
- Sugar Land, Texas
- Business Model
- B2B
- Website
- interobiosystems.com
- Last Round
- Pre-SeedJun 2025
About
Intero Biosystems develops gut organoid technology — miniaturized, lab-grown intestinal tissue models — for use in personalized medicine and pharmaceutical drug testing. The company's platform enables more accurate preclinical testing by using patient-derived tissue to predict individual drug responses, reducing reliance on animal models and improving drug development success rates.
Summary
Intero Biosystems is a Healthcare company based in Sugar Land, United States. Its most recent funding was a Pre-Seed round in Jun 2025.
Tech & App Stack
1 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Funding History
No funding data available yet.
Know something? Help us improve our data.
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Healthcare company in Europe